Bleichroeder LP’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-182,500
Closed -$6.17M 108
2021
Q2
$6.17M Hold
182,500
0.93% 26
2021
Q1
$4.27M Buy
+182,500
New +$5.53M 0.72% 29

Bleichroeder LP's CNST Position: Q3 2021 in Review

Bleichroeder LP sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 182,500 shares — an estimated $6.17M sold.

Bleichroeder LP first reported a position in CNST in Q1 2021 and held it in 2 quarters. The position peaked at $6.17M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Bleichroeder LP reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Bleichroeder LP sold 182,500 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $6.17M.
  • Bleichroeder LP first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2021 and held it in 2 quarters.
  • Bleichroeder LP's Constellation Pharmaceuticals, Inc. position peaked at $6.17M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Bleichroeder LP's 13F filing for Q3 2021, filed 15 Nov 2021.